Medtelligence: Linking Science to Clinical Practice - Medtelligence

Medtelligence Hero

Linking Science
to Clinical Practice

Innovative, high-quality medical education for clinicians in cardiology and other specialties.

Featured

Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
CME/CE
Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
Richard Lafayette, MD, FACP; Ankana Daga, MD
0.25 credits
- Richard Lafayette, MD, FACP
- Ankana Daga, MD
0.25 credits
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
CME/CE
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits
- Antoine Lanot, MD, PhD
- Gil Yosipovitch, MD
0.25 credits
MinuteCE®
Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
Ahmad Masri, MD, MS; Michael Nassif, MD, MSc
1.00 credit 8 episodes
- Ahmad Masri, MD, MS
- Michael Nassif, MD, MSc
- Anjali Owens, MD
1.00 credit 8 episodes
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
CME/CE
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD; Muh Geot Wong, MBBS, PhD
0.25 credits
- An De Vriese, MD, PhD
- Muh Geot Wong, MBBS, PhD
0.25 credits

Popular

Leadoff Hitter – Spotting High-Risk Players
Leadoff Hitter – Spotting High-Risk Players
MinuteCE®
Leadoff Hitter – Spotting High-Risk Players
J.A. Randy Englert, MD, FACC
0.75 program credits
- J.A. Randy Englert, MD, FACC
0.75 program credits
Turning the Double Play – Comprehensive Secondary Prevention
Turning the Double Play – Comprehensive Secondary Prevention
MinuteCE®
Turning the Double Play – Comprehensive Secondary Prevention
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits
Crossing Home Plate – Building a Winning Team Culture
Crossing Home Plate – Building a Winning Team Culture
MinuteCE®
Crossing Home Plate – Building a Winning Team Culture
J.A. Randy Englert, MD, FACC; Matthew Malachowski, Pharm. D., MHA
0.75 program credits
- J.A. Randy Englert, MD, FACC
- Matthew Malachowski, Pharm. D., MHA
0.75 program credits
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
CME/CE
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD; Julio Núñez, MD, PhD
0.25 credits
- Patrick Rossignol, MD, PhD
- Julio Núñez, MD, PhD
0.25 credits
Safety in oHCM Therapy: How and When to Transition Treatment?
Safety in oHCM Therapy: How and When to Transition Treatment?
MinuteCE®
Safety in oHCM Therapy: How and When to Transition Treatment?
Anjali Owens, MD
1.00 program credit
- Anjali Owens, MD
1.00 program credit
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
CME/CE
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, PhD, FRCP; Claudia Seikrit, MD
0.25 credits
- Chee Kay Cheung, MBChB, PhD, FRCP
- Claudia Seikrit, MD
0.25 credits
Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
Cardiology
Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
Florian Rader, MD
- Florian Rader, MD
SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Cardiology
SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Joseph Rossano, MD
- Joseph Rossano, MD